Delivery Order SPE2D020D0014-SPE2D325F059A

Award Date 5/14/25
Potential Completion Date 5/19/25
Potential Value $1.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of estrogen conjugated injections, a critical medical product. The contract has a ceiling value of $1,909.39 and an ultimate completion date of February 18, 2025. This order is part of Pfizer's larger role as a prime contractor for the DLA, providing a wide range of pharmaceutical products,...
The Defense Logistics Agency Troop Support Medical awarded a $506,960 delivery order to Pfizer Inc. for conjugated estrogens injection solution. The order was placed against an existing contract vehicle to supply 2 million milliliters of the product. Pfizer will deliver the medication from its New York manufacturing facility to an unspecified customer by July 18, 2023. The firm fixed price contract has no set aside designation. As a major provider of pharmaceuticals to the Department of Defense,...
This is a $924,719.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract will run through September 30, 2025 and provides for the supply of various pharmaceuticals and medical products, including controlled substances, antibiotics, and vaccines. Pfizer, a global pharmaceutical corporation, serves as the prime contractor on this award. The contract is not set-aside and Pfizer has been awarded several significant Indefinite...
This is a $380,405.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract does not have a set-aside designation. Pfizer, a global pharmaceutical company, is providing a variety of pharmaceutical products and supplies to support healthcare initiatives across multiple federal agencies. This contract is part of Pfizer's larger Indefinite Delivery Vehicle (IDV) contracts, including a $7.31 billion Federal Supply...
The U.S. Defense Logistics Agency Troop Support Medical awarded a $148,844.52 firm fixed price delivery order to Pfizer Inc. to provide Vancomycin 1,000 mg intravenous injection. This order was not set aside for any particular business type. Pfizer is a large pharmaceutical company that provides a variety of pharmaceutical products and services to U.S. government agencies through federal contract awards. As the prime contractor, Pfizer will deliver the injectable pharmaceutical product...
This is a $3,141.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines (0.9mL) during the 2024-2025 time period, including potential 4-year extensions. The award is not set-aside and has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,162.70 contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with a performance period from February 2023 through February 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses. The $1,570.70 firm fixed-price contract has an ultimate completion date of April 29, 2025 and is not set aside. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer. The contract is for $673,624.25 and has an ultimate completion date of September 30, 2024. The contract is for other medical supplies, and it is not set aside for small businesses. Pfizer is the prime contractor and there is no information provided about any major subcontractors. The DLA Troop Support Medical is responsible...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,100.15 and a period of performance through May 8, 2025. It is not designated as a set-aside contract, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop...
  • SPE2D020D0014
    Indefinite Delivery Contract
  • SPE2D020D0014-SPE2D325F059A
    Delivery Order

This is a delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of Estrogens, Conjugated 5mg/ml Injection. The $1,363.85 firm fixed-price contract has a completion date of May 19, 2025 and does not utilize a set-aside designation. Pfizer holds two significant Indefinite Delivery Vehicle (IDV) contracts with the government, including a $46,893,140 contract for Bevacizumab injections and a $2,007,801,000 Vaccines for Children (VFC) program contract with the Centers for Disease Control and Prevention, highlighting the company's role as a critical supplier of pharmaceuticals and vaccines to federal healthcare programs.

Generated 8/13/25, 10:45 AM